References

1. Mebazaa A et al. Lancet 2022;400:1938–52

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis online through the pharmacovigilance intake (PVI) tool at www.novartis.com/report or alternatively email medinfo.uk@novartis.com or call 01276 698370.

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis online through the pharmacovigilance intake (PVI) tool at www.novartis.com/report or alternatively email medinfo.uk@novartis.com or call 01276 698370.

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis online through the pharmacovigilance intake (PVI) tool at www.novartis.com/report or alternatively email medinfo.uk@novartis.com or call 01276 698370.

• Understand secondary prevention measures to implement to reduce the risk of further events in patients with established disease
• Obtain an overview of the pertinent lifestyle and medical intervention strategies available to improve outcomes
• Recognise the importance of personalised approaches to treatment to improve engagement and adherence
• Understand engaging with older patients around technology and tools they can use to maximise these resources

Speakers

Gayle Campbell Lead Heart Failure Pharmacist, Guy’s and St Thomas’ NHS Foundation Trust
Professor Pardeep Jhund Professor of Cardiology and Epidemiology and Honorary Consultant Cardiologist, University of Glasgow

Learning module instructions

This BJC learning module has a recommended award of 1 CPD credit for completion (1 hour of learning). Completion requires a score of at least 75%. If less time is spent learning then you should claim a reduced credit value. After you have successfully completed the test you will be able to download your certificate.

References

1. McDonagh TA et al. Eur Heart J. 2021;42:3599–3726
2. Mebazaa A et al. Lancet. 2022;400:1938–1952
3. NICE. Chronic heart failure in adults: diagnosis and management. 2018. Available at: https://www.nice.org.uk/guidance/ng106/resources/chronic-heart-failure-in-adults-diagnosis-and-management-pdf-66141541311685 (accessed January 2025)

• Peripheral arterial and aortic disease
• Elevated blood pressure and hypertension
• Chronic coronary syndromes
• Atrial fibrillation

Speakers

Dr Paul Foley, Cardiologist, The Great Western Hospitals NHS Foundation Trust
Professor Terry McCormack, Professor of Primary Care Cardiovascular Medicine; Immediate Past President of British and Irish Hypertension Society; Institute of Clinical and Applied Health Research, Hull York Medical School; Whitby Group Practice, Whitby